Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · New Mexico | Vitreoretinal surgery · California | |
|---|---|---|
| Surgeons, 2024 | 8 | 94 |
| Medicare fee-for-service cases | 477 | 7,488 |
| Growth since 2019 (Medicare FFS) | −2%/yr | −1.9%/yr |
| Forecast cases (Medicare FFS) | 440 in 2030 | 8,080 in 2030 |
| Forecast growth | −1.5%/yr to 2030 | +1.3%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.1 | 2.3 |
| Medicare Advantage share | 54% | 56% |
| Out of hospital | 54% (+6 pts since 2019) | 59% (+13 pts since 2019) |
| Cases per surgeon | 60 | 80 |
| Top 10 surgeons' share | 100% | 30% |
| Surgeons growing | 0 | 13 |
| New since the base year | 1 | 15 |
| Likely to stop billing it | 1 by 2026 | 16 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $1,561 | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.